Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.64 |
| ▸ | MGLL | Q99685 | 2/20 | 0.55 |
| ▸ | DHODH | Q02127 | 2/20 | 0.49 |
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
| ▸ | FDPS | P14324 | 1/20 | 0.47 |
| ▸ | MMP8 | P22894 | 1/20 | 0.47 |
| ▸ | MMP14 | P50281 | 1/20 | 0.47 |
| ▸ | CA9 | Q16790 | 1/20 | 0.47 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 2/20 | 0.46 |
| ▸ | CNR1 | P21554 | 3/20 | 0.45 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.44 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.44 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28214132 | 0.96 | ALDH1A1 (0.56) | ALDH1A1MGLLDHODHCA2FDPS | |
| SCHEMBL27895559 | 0.89 | ALDH1A1 (0.65) | ALDH1A1MGLLDHODHCA2FDPS | |
| SCHEMBL14471626 | 0.85 | ALDH1A1 (0.60) | ALDH1A1MGLLDHODHCA2FDPS | |
| SCHEMBL28254478 | 0.85 | ALDH1A1 (0.60) | ALDH1A1MGLLDHODHCA2FDPS | |
| SCHEMBL11194081 | 0.85 | CNR1 (0.50) | ALDH1A1MGLLDHODHCNR1LIMK1 | |
| SCHEMBL4429931 | 0.84 | TRIM24 (0.59) | ALDH1A1MGLLMEN1KMT2A | |
| SCHEMBL12129057 | 0.82 | ALDH1A1 (0.67) | ALDH1A1LIMK1MEN1KMT2A | |
| SCHEMBL18654163 | 0.81 | HDAC6 (0.60) | ALDH1A1LIMK1MEN1KMT2A | |
| SCHEMBL223423 | 0.80 | ALDH1A1 (0.73) | ALDH1A1MGLLDHODHMMP8MMP14 | |
| SCHEMBL14418354 | 0.80 | ALDH1A1 (0.73) | ALDH1A1MGLLDHODHMMP8MMP14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108883122-A | C-glycoside compounds useful for the treatment of diseases | 菲姆布里昂医疗公司 | 2018-11-23 | — | — | CN | claimed |
| CN-108778288-A | It can be used for treating antagonist derived from the mannose of the FimH of disease | 菲姆布里昂医疗公司 | 2018-11-09 | — | — | CN | claimed |
| CN-108883122-A | C-glycoside compounds useful for the treatment of diseases | 菲姆布里昂医疗公司 | 2018-11-23 | — | — | CN | disclosed |
| CN-108778288-A | It can be used for treating antagonist derived from the mannose of the FimH of disease | 菲姆布里昂医疗公司 | 2018-11-09 | — | — | CN | disclosed |
| CN-107922394-A | 3 tetrazole radical benzene, 1,2 disulfonic acid amide derivative as metal beta lactamase restrainer | 默沙东公司 | 2018-04-17 | — | — | CN | disclosed |
| CN-104903300-B | COMT inhibitor | 霍夫曼-拉罗奇有限公司 | 2018-04-17 | — | — | CN | disclosed |
| CN-105102449-B | Antiviral compound | 豪夫迈·罗氏有限公司 | 2017-06-13 | — | — | CN | disclosed |
| CN-103442566-A | Compounds for treatment of cancer | GTX INC | 2013-12-11 | — | — | CN | disclosed |
| CN-102883607-A | Compounds for the treatment of cancer | GTX INC (US) | 2013-01-16 | — | — | CN | disclosed |
| EP-2543437-A2 | HOMOGENEOUS ASYMMETRIC HYDROGENATION CATALYST | Takasago International Corporation (JP) | 2013-01-09 | — | — | EP | disclosed |
| CN-102746285-A | Compounds and compositions as HEDGEHOG pathway modulators | IRM LLC | 2012-10-24 | — | — | CN | disclosed |
| CN-102170873-A | Smoothied antagonism for treating disorders associated with HEDGEHOG pathways | NOVARTIS AG | 2011-08-31 | — | — | CN | disclosed |
| US-5530138-A | A PYRROLIZINE DERIVATIVE; EFFECTIVE IN THE TREATMENT OF SENILE DEMENTIA | SANWA KAGAKU KENKYUSHO CO., LTD. (JP) | 1996-06-25 | — | — | US | disclosed |
| EP-0647642-A1 | 1-Azabicyclo(3.3.0)octane derivatives and their use | SANWA KAGAKU KENKYUSHO CO., LTD. (JP) | 1995-04-12 | — | — | EP | disclosed |